[Our experience in the treatment of acute lymphoblastic leukemias (ALL) having different risk levels with the BFM-83 therapeutic protocol].
Bernacer
M
M
Fundación Jiménez Díaz, Servicio de Pediatría, Madrid.
Aracil
J
J
Contra
T
T
Gil
C
C
López
J
J
López-Ibor
B
B
Martín
N
N
Melero
C
C
Valverde
F
F
Vecilla
C
C
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002985:Clinical Protocols; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D012307:Risk Factors
D000970:Antineoplastic Agents
Nuestra experiencia en el tratamiento de las leucemias agudas linfoblásticas (LAL) de riesgo con el protocolo terapéutico BFM-83.